IMNM
#1689
Immunome, Inc. - Common Stock
27.5 7 USD
-0.05%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-4.50%
Monthly Change
+19.87%
6 month change
+29.99%
Year Change
+189.91%
Previous Close
28.8 7
Open
27.5 7
Low
27.5 7
High
27.5 7
Volume
112
Financials
- Market Capitalization 3.13 B
- Employee 177
- Founded 2006
- CEO N/A
- Website www.immunome.com
- Headquarter Delaware, United States
- FIGI BBG00BR93ZG8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-8.84
Price to sales ratio
100.55
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1638 |  GPCR Structure Therapeutics Inc - American Depositary Shares | 47.37 USD | -3.76% | -2.55% | +0.17% | +77.15% | 3.38 B USD | ||
| 1682 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 71.76 USD | -0.22% | -1.54% | +23.98% | +8.63% | 3.15 B USD | ||
| 1698 |  NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 25.90 USD | -3.32% | -6.97% | -7.27% | -28.59% | 3.10 B USD | ||
| 1703 |  IRON Disc Medicine, Inc. - Common Stock | 80.03 USD | -3.05% | +0.19% | +7.90% | +34.46% | 3.07 B USD |
Frequently asked questions about Immunome, Inc.
What is the Immunome, Inc. stock price today?
The current price of Immunome, Inc. (IMNM) is 27.57. Over the past 24 hours, the stock has changed by -4.50%. Follow the IMNM chart for real-time price dynamics.
What is the stock ticker of Immunome, Inc.?
Immunome, Inc. trades under the ticker IMNM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Immunome, Inc. stock going up?
IMNM has changed by -4.07% over the last week, +19.87% over the last month, and +189.91% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Immunome, Inc.?
Immunome, Inc. currently has a market capitalization of 3.13 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Immunome, Inc. earnings last quarter?
Last quarter, Immunome, Inc. reported earnings of -0.65 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Immunome, Inc. revenue for the last quarter?
Immunome, Inc. reported quarterly revenue of 5.01 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Immunome, Inc. net income for the last quarter?
Immunome, Inc. reported net income of -73.13 M for the last quarter. The previous quarter showed -53.84 M, which means net income changed by -35.83%.
How many employees does Immunome, Inc. have?
As of the latest available data, Immunome, Inc. has 177 employees. Workforce size can provide additional context about the company's scale and operations.
What is Immunome, Inc. EBITDA?
Immunome, Inc. EBITDA is -72.17 M, and its EBITDA margin is -1 441.09%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Immunome, Inc. stock?
You can buy Immunome, Inc. (IMNM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Immunome, Inc. stock?
Investing in Immunome, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMNM chart and related analysis on metatrader.com as part of your research.